Giving antibodies 'eyes' may help target hidden KRAS mutations in cancer cells

Antibodies are like "guided missiles" that find and attack cancer cells, but cancer-causing mutations inside cells have ...
Nasdaq

Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next ...

IMA402 and IMA401 TCR Bispecifics showed favorable tolerability at RP2D as well as deep and durable responses in heavily pre-treated, last-line patients with a range of solid tumors IMA402 PRAME ...
WGN-TV

Captain T Cell Closes Financing Round to Advance its Proprietary, Next-Generation TCR-T Pipeline Into the Clinic

Schoenefeld/Berlin, Germany, November 17, 2025 --- Captain T Cell, a biotechnology company developing next-generation TCR-T cell therapies for solid tumors, today announced the successful closing of ...
GEN

High-Titer CHO Expression of T Cell-Related Proteins

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T persistence and function. Additionally, there is a growing trend towards ...
ascopubs.org

Identifying peripheral cancer-associated TCR signals for the early-detection of lung cancer.

Investigating the association of blood-to-tissue tumor mutation burden (TMB) ratio with overall survival and intratumor heterogeneity (ITH) in advanced NSCLC. This is an ASCO Meeting Abstract from the ...